Endogenous secretory leukocyte protease inhibitor inhibits microbial‐induced monocyte activation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Endogenous secretory leukocyte protease inhibitor inhibits microbial‐induced monocyte activation ; day:22 ; month:12 ; year:2022 ; extent:13
European journal of immunology ; (22.12.2022) (gesamt 13)
- Urheber
-
Nugteren, Sandrine
Simons‐Oosterhuis, Ytje
Menckeberg, Celia L.
Hulleman‐van Haaften, Danielle H.
Lindenbergh‐Kortleve, Dicky J.
Samsom, Janneke N.
- DOI
-
10.1002/eji.202249964
- URN
-
urn:nbn:de:101:1-2022122314034451210654
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nugteren, Sandrine
- Simons‐Oosterhuis, Ytje
- Menckeberg, Celia L.
- Hulleman‐van Haaften, Danielle H.
- Lindenbergh‐Kortleve, Dicky J.
- Samsom, Janneke N.
Ähnliche Objekte (12)
Secretory Leukocyte Protease Inhibitor in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma
Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen : die Rolle der Antileukoproteinase "Secretory Leukocyte Protease Inhibitor" (SLPI)
Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human osteoblast adhesion and differentiation
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen: die Rolle der Antileukoproteinase „Secretory Leukocyte Protease Inhibitor“ (SLPI)
Die Antileukoproteinase "secretory leukocyte protease inhibitor" (SLPI) und ihre potentielle Bedeutung für die Prävention von HPV-Infektionen
Regulation der "Secretory Leukocyte Protease Inhibitor"-Expression in Magenepithelzellen unter dem Einfluss der Infektion mit Helicobacter pylori
Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-κB and Akt pathways
Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection
Salivary secretory leukocyte protease inhibitor levels in patients with stage 3 grade C periodontitis: a comparative cross-sectional study
Secretory Leukocyte Protease Inhibitor in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma
Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen : die Rolle der Antileukoproteinase "Secretory Leukocyte Protease Inhibitor" (SLPI)
Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human osteoblast adhesion and differentiation
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen: die Rolle der Antileukoproteinase „Secretory Leukocyte Protease Inhibitor“ (SLPI)
Die Antileukoproteinase "secretory leukocyte protease inhibitor" (SLPI) und ihre potentielle Bedeutung für die Prävention von HPV-Infektionen
Regulation der "Secretory Leukocyte Protease Inhibitor"-Expression in Magenepithelzellen unter dem Einfluss der Infektion mit Helicobacter pylori
Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-κB and Akt pathways
Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection
Salivary secretory leukocyte protease inhibitor levels in patients with stage 3 grade C periodontitis: a comparative cross-sectional study
Secretory Leukocyte Protease Inhibitor in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma
Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen : die Rolle der Antileukoproteinase "Secretory Leukocyte Protease Inhibitor" (SLPI)
Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human osteoblast adhesion and differentiation
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen: die Rolle der Antileukoproteinase „Secretory Leukocyte Protease Inhibitor“ (SLPI)
Die Antileukoproteinase "secretory leukocyte protease inhibitor" (SLPI) und ihre potentielle Bedeutung für die Prävention von HPV-Infektionen
Regulation der "Secretory Leukocyte Protease Inhibitor"-Expression in Magenepithelzellen unter dem Einfluss der Infektion mit Helicobacter pylori
Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-κB and Akt pathways
Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection